Dianabol vs Oxytocin
Well Studied vs FDA Approved
monitor Mechanism-based · 51% Both Dianabol and Oxytocin can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar).
Molecular Data
Dianabol Oxytocin
Weight 300.44 Da 1,007.19 Da
Half-life ~4-6 hours 3-6 minutes
Chain — 9 amino acids
Type 17-alpha-alkylated anabolic steroid (C20H28O2) Cyclic nonapeptide
Key Benefits
Dianabol
01 Rapid and dramatic increases in muscle mass and bodyweight
02 Significant strength gains within the first 1-2 weeks
03 Enhanced nitrogen retention and protein synthesis
04 Improved glycogenolysis and muscular endurance
05 Pronounced muscle fullness and pumps from increased intracellular water and glycogen
06 Effective oral kickstart while waiting for injectable compounds to saturate
07 One of the fastest-acting anabolic compounds available
Oxytocin
01 FDA-approved for labor induction with precise dosing via IV
02 Immediate onset in obstetric settings
03 Established safety profile in clinical use
04 Researched for anxiety, PTSD, autism, sexual dysfunction
Dosing Protocols
Dianabol
20-50 mg/day / Split doses throughout the day
Oxytocin
Intranasal: 20-24 IU; Injectable: 10-40 IU; Sublingual: 50-100 IU / As needed for social/sexual support, or 1-2x daily for anxiety/PTSD protocols; max 1 dose per 24hr for sexual function
Labor Induction 0.5-2 mU/min initial, titrate to 1-2 mU/min every 30-60 min Continuous IV infusion
Postpartum Hemorrhage Prevention 10 units IM or 10-40 units in IV solution Single dose after placental delivery
Side Effects
Dianabol
Significant water retention and bloating (estrogen-mediated)
Elevated blood pressure from fluid retention and increased red blood cell mass
Liver stress with elevated ALT/AST enzymes (dose and duration dependent)
Back pumps (painful lower back cramping during exercise)
Increased appetite
Oily skin and acne
Suppression of endogenous testosterone production (HPTA suppression)
Mild mood changes (increased aggression, irritability, or euphoria)
Oxytocin
Mild headache
Nasal irritation (intranasal)
Nausea or vomiting
Transient blood pressure changes
Contraindications
Pre-existing liver disease or impaired hepatic function
Active or history of hormone-sensitive cancers (prostate, breast)
Uncontrolled hypertension or significant cardiovascular disease
Elevated hematocrit (above 54%) at baseline
Concurrent use of other hepatotoxic oral steroids (do not stack C17-aa orals)
Pregnancy or potential exposure to pregnant women
Heavy alcohol use (compounded hepatotoxicity risk)
Cholestatic liver conditions or history of drug-induced liver injury
Certain obstetric conditions (see prescribing info)
Pregnancy (without medical supervision)
Active sinus infection (intranasal)
Severe hyponatremia
Research Evidence
Dianabol Oxytocin
Status Well Studied FDA Approved
References 5 studies 3 studies
Latest 2017 —
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.